搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shigella dysenteriae serotype 1 Cysteine--tRNA ligase (cysS) CSB-YP653444SGF
CSB-EP653444SGF
CSB-BP653444SGF
CSB-MP653444SGF
CSB-EP653444SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 UPF0253 protein yaeP (yaeP) CSB-YP653445SGF
CSB-EP653445SGF
CSB-BP653445SGF
CSB-MP653445SGF
CSB-EP653445SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Outer membrane protein assembly factor YaeT (yaeT), partial CSB-YP653446SGF
CSB-EP653446SGF
CSB-BP653446SGF
CSB-MP653446SGF
CSB-EP653446SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) CSB-YP653447SGF
CSB-EP653447SGF
CSB-BP653447SGF
CSB-MP653447SGF
CSB-EP653447SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Dephospho-CoA kinase (coaE) CSB-YP653448SGF
CSB-EP653448SGF
CSB-BP653448SGF
CSB-MP653448SGF
CSB-EP653448SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP653449SGF
CSB-EP653449SGF
CSB-BP653449SGF
CSB-MP653449SGF
CSB-EP653449SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP653450SGF
CSB-EP653450SGF
CSB-BP653450SGF
CSB-MP653450SGF
CSB-EP653450SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 4-hydroxythreonine-4-phosphate dehydrogenase (pdxA) CSB-YP653451SGF
CSB-EP653451SGF
CSB-BP653451SGF
CSB-MP653451SGF
CSB-EP653451SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Crotonobetainyl-CoA:carnitine CoA-transferase (caiB) CSB-YP653452SGF
CSB-EP653452SGF
CSB-BP653452SGF
CSB-MP653452SGF
CSB-EP653452SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Isoleucine--tRNA ligase (ileS), partial CSB-YP653453SGF
CSB-EP653453SGF
CSB-BP653453SGF
CSB-MP653453SGF
CSB-EP653453SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 UPF0246 protein yaaA (yaaA) CSB-YP653454SGF
CSB-EP653454SGF
CSB-BP653454SGF
CSB-MP653454SGF
CSB-EP653454SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Regulator of microtubule dynamics protein 1 (FAM82B) CSB-YP653455BO
CSB-EP653455BO
CSB-BP653455BO
CSB-MP653455BO
CSB-EP653455BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Protein C10 CSB-YP653456BO
CSB-EP653456BO
CSB-BP653456BO
CSB-MP653456BO
CSB-EP653456BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Zinc finger C2HC domain-containing protein 1B (ZC2HC1B) CSB-YP653457BO
CSB-EP653457BO
CSB-BP653457BO
CSB-MP653457BO
CSB-EP653457BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine WD repeat-containing protein 53 (WDR53) CSB-YP653458BO
CSB-EP653458BO
CSB-BP653458BO
CSB-MP653458BO
CSB-EP653458BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine MORN repeat-containing protein 2 (MORN2) CSB-YP653459BO
CSB-EP653459BO
CSB-BP653459BO
CSB-MP653459BO
CSB-EP653459BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Cytoplasmic dynein 2 light intermediate chain 1 (DYNC2LI1) CSB-YP653460BO
CSB-EP653460BO
CSB-BP653460BO
CSB-MP653460BO
CSB-EP653460BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Isochorismatase domain-containing protein 2, mitochondrial (ISOC2) CSB-YP653461BO
CSB-EP653461BO
CSB-BP653461BO
CSB-MP653461BO
CSB-EP653461BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3) CSB-YP653462BO
CSB-EP653462BO
CSB-BP653462BO
CSB-MP653462BO
CSB-EP653462BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine DNA-directed RNA polymerases I and III subunit RPAC1 (POLR1C) CSB-YP653463BO
CSB-EP653463BO
CSB-BP653463BO
CSB-MP653463BO
CSB-EP653463BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>